TrialKey, developed by Opyl, is a technology platform designed to streamline and enhance the clinical trial process. It focuses on improving patient recruitment and engagement through innovative digital solutions. The platform leverages data analytics and artificial intelligence to optimize trial design and execution, ultimately aiming to accelerate the delivery of new therapies to market. TrialKey is tailored for sponsors and researchers looking to enhance the efficiency and effectiveness of their clinical studies.